Hans Prenen hoogleraar

Publicaties Hans Prenen

Highlights in gastro-intestinal cancer

Bron
Belgian journal of medical oncology - ISSN 1784-7141-12 (2018) p. 182-188
Auteur(s)

Amivantamab monotherapy in chemorefractory RAS/BRAF wild-type metastatic colorectal cancer : results from OrigAMI-1, an open-label, phase Ib/II study

Bron
Journal of clinical oncology - ISSN 0732-183X-44:17 (2026) p. 1624-1634
Auteur(s)
    Paul E. Oberstein, J. Randolph Hecht, Kanwal Raghav, Filippo Pietrantonio, Dirk Arnold, Victor Moreno, Eric Van Cutsem, Rozita Abdul Malik, Yong Sang Hong, Myung Ah Lee, Harvey Yu-Li Su, Jeeyun Lee, Sreenivasa Chandana, Marcia Cruz-Correa, Ying Yuan, Azura Ahmad, Kuan-Ming Lai, Hung-Chih Hsu, Eric Xueyu Chen, Elena Elez, Chia-Chi Lin, Carlos Lopez, Hans Prenen, Susana Rosello-Keranen, Hector Velez, Yu-Min Yeh, Volker Heinemann, Cathy Eng, Seung-Hoon Beom, Sabine Tejpar, Sanjib Chowdhury, Xuesong Lyu, Medha Kamat, Joshua C. Curtin, Bharvin Patel, John Xie, Rianka Bhattacharya, Robert W. Schnepp, Emrullah Yilmaz, Ryota Iwasawa, Mahesh Daksh, Patricia Lorenzini, Meena Thayu, Mahadi Baig, Han Sang Kim, Sae-Won Han

Phase I study of mosperafenib, a novel paradox breaker B-Raf proto-oncogene serine/threonine kinase (BRAF) inhibitor, in patients with BRAF V600-mutant solid tumors

Bron
Journal of clinical oncology - ISSN 0732-183X-44:14 (2026) p. 1337-1348
Auteur(s)
    Maria Vieito, Elisa Fontana, Catherine H. Han, Eduardo Castanon, David J. Pinato, Oliver Bechter, Rikke L. Eefsen, Irene Moreno, Hans Prenen, Reinhard Dummer, Ruth Plummer, Gabriel Schnetzler, Martin Kornacker, Piergiorgio Pettazzoni, Florian Renner, Mahdi About, Martha L. Serrano-Serrano, Christina Godfried Sie, Abiraj Keelara, Andreas Roller, David Dejardin, Elisa Cinato, Tomi Fakolade, Ernesto Guarin, Nick Flinn, Nicole A. Kratochwil, Nino Keshelava

Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patterns

Bron
Cancer immunology and immunotherapy - ISSN 0340-7004-75:4 (2026) p. 1-17
Auteur(s)

Erdafitinib in patients with FGFR-altered advanced or metastatic cholangiocarcinoma

Bron
Clinical cancer research - ISSN 1078-0432-32:6 (2026) p. 1136-1144
Auteur(s)
    Shubham Pant, Joon Oh Park, Wu-Chou Su, Yohann Loriot, Omar Carranza, Marcelo Corassa, Toshihiko Doi, Shukui Qin, Josep Tabernero, Hans Prenen, Gunnar Folprecht, Helen Winter, Graziela Z. Dal Molin, Lin Shen, Jiaqi Qian, Huimin Liao, Shibu Thomas, Hussein Sweiti, Spyros Triantos, Yin-Hsun Feng